Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;39(7):1186-1188.
doi: 10.1007/s12264-023-01031-y. Epub 2023 Feb 4.

Linking Genetic Risks to Pathological α-Synuclein Transmission in Parkinson's Disease

Affiliations
Comment

Linking Genetic Risks to Pathological α-Synuclein Transmission in Parkinson's Disease

Xiaoqing Mi et al. Neurosci Bull. 2023 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors claim that there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Intercellularly-transmitted α-syn aggregates interact with cell surface receptors for internalization into neurons and glia. The membrane receptors GPNMB, LAG3, α3-NKA, PrPC, FcγRIIB, HSPG, TLR2, and Cx32 have been shown to interact with extracellular α-syn and facilitate its internalization into neurons. The internalized α-syn seeds the recruitment of endogenous α-syn aggregates, leading to pathological propagation. Glia also expresses membrane receptors responsible for α-syn internalization and thus trigger α-syn neurotoxicity. For example, PrPC, HSPG, and TLR2 have been reported on the cell surface of astrocytes, LAG3, PrPC, HSPG, and TLR2 on microglia, and HSPG and Cx32 on oligodendrocytes. GPNMB, glycoprotein non-metastatic melanoma protein B; LAG3, lymphocyte activation gene 3; α3-NKA, α3 subunit of the Na+/K+-ATPase complex; PrPC, cellular prion protein; HSPG, heparan sulfate proteoglycan; TLR2, toll-like receptor 2; Cx32, connexin-32; α-syn, α-synuclein.

Comment on

  • GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
    Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS. Diaz-Ortiz ME, et al. Science. 2022 Aug 19;377(6608):eabk0637. doi: 10.1126/science.abk0637. Epub 2022 Aug 19. Science. 2022. PMID: 35981040 Free PMC article.

References

    1. Peng C, Trojanowski JQ, Lee VMY. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16:199–212. doi: 10.1038/s41582-020-0333-7. - DOI - PMC - PubMed
    1. Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Res Rev. 2018;42:72–85. doi: 10.1016/j.arr.2017.12.007. - DOI - PubMed
    1. Foo JN, Chew EGY, Chung SJ, Peng R, Blauwendraat C, Nalls MA, et al. Identification of risk loci for parkinson disease in asians and comparison of risk between asians and Europeans: A genome-wide association study. JAMA Neurol. 2020;77:746–754. doi: 10.1001/jamaneurol.2020.0428. - DOI - PMC - PubMed
    1. Bae EJ, Kim DK, Kim C, Mante M, Adame A, Rockenstein E, et al. LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation. Nat Commun. 2018;9:3465. doi: 10.1038/s41467-018-05958-z. - DOI - PMC - PubMed
    1. Henderson MX, Sedor S, McGeary I, Cornblath EJ, Peng C, Riddle DM, et al. Glucocerebrosidase activity modulates neuronal susceptibility to pathological α-synuclein insult. Neuron. 2020;105:822–836.e7. doi: 10.1016/j.neuron.2019.12.004. - DOI - PMC - PubMed

Publication types

Substances